Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Sep-Oct;41(5):297-303.

[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens]

[Article in Spanish]
Affiliations
  • PMID: 2076309

[Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens]

[Article in Spanish]
F Esteban et al. Acta Otorrinolaringol Esp. 1990 Sep-Oct.

Abstract

A series of 60 primary laryngeal and hypopharyngeal tumours, 24 lymph node metastasis and normal tissue were evaluated in frozen sections for the expression of MHC class I antigens, using monoclonal antibodies. Normal distant mucosa of the larynx reacted to anti class I antibodies. In 13 primary tumours HLA class I antigens were not found. The remaining 47 showed a strong reaction to anti HLA-ABC (heavy chain) and anti beta 2-microglobulin, although in 5 cases staining was not observed with anti HLA-A locus specific monoclonal antibodies. Other tumour showed a selective loss of HLA-B antigens. These selective losses were confirmed using the correspondent anti-HLA polymorphic monoclonal antibodies. We have found differences in HLA class I expression when comparing primary tumours and autologous metastasis (3/15 cases). Finally, to further analyse the mechanism responsible for the HLA phenotypic changes observed, immunoprecipitation and SDS-PAGE of class I antigens, Northern and Southern blot analysis of MHC class I genes were performed. We have not detected class I gene rearrangement using HLA coding and locus specific non coding probes. However we have found a class I transcription defect in a class I negative tumour.

PubMed Disclaimer

Similar articles

Publication types

MeSH terms

LinkOut - more resources